Oncology Market - Trends Forecast Till 2028

Oncology Market By Areas (Medical, Surgical, Radiation), Cancer Type (Haematology Cancer, Ovarian Cancer, Pancreatic Cancer, Lung Cancer, Bladder Cancer, Prostate Cancer, Breast Cancer, Kidney Cancer, Others), Treatment (Combination Therapy, Adjuvant Therapy, Supportive Therapy, Palliative Care, Others), Technology (Car-T Cell Therapy, CRISPR/CAS9, Others), Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade, Zytiga, Xtandi, Others), Stage (Stage I, Stage II, Stage III, Stage IV), End Users (Hospitals, Specialty Clinics, Oncology Centers, Surgical Centers, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: September, 2020

Base Year Estimate: 2019

Report ID: D-HC-OM-44

Format:  

Number of Pages: 211

Domain: Healthcare

Oncology Market – Trends Forecast Till 2028

Global oncology market is anticipated to reach USD 175.4 billion by 2020 growing at a CAGR of 7.1% during the forecasting period, 2020-2028. Oncology is one of the branches of medicine which deals prevention, diagnosis, and treatment of cancer. It includes the medical, surgical and radiation oncology. Medical oncology is of various types like chemotherapy, targeted therapy and immunotherapy. Factors such as increasing demand for minimally invasive procedures and the increasing number of targeted population are some of the major drivers for the oncology market

Needle Market – Trends Forecast Till 2028

Global oncology market is segmented into areas, cancer type, treatment, technology, drugs, stage, end-user and geography.

Areas segment is segmented into Medical, Surgical and Radiation. Medical segment is further segmented into chemotherapy, Targeted Therapy and Immunotherapy. Surgical segment is further segmented into Image-Guided Biopsy, Fine Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Excisional Biopsy, Shave Biopsy, Punch Biopsy, Endoscopic Biopsy, Laparoscopic Biopsy, Bone Marrow Aspiration and Biopsy, Liquid Biopsy.

Cancer Type segment is segmented into Haematology Cancer, Ovarian Cancer, Pancreatic Cancer, Lung Cancer, Bladder Cancer, Prostate Cancer, Breast Cancer, Kidney Cancer and Others

Treatment segment is segmented into Combination Therapy, Adjuvant Therapy, Supportive Therapy, Palliative Care and Others

Technology segment is segmented into Car-T Cell Therapy, CRISPR/CAS9 and Others

Drugs segment is segmented into Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade, Zytiga, Xtandi and Others

Stage segment is segmented into Stage I, Stage II, Stage III and Stage IV

End Users segment is segmented into Hospitals, Specialty Clinics, Oncology Centers, Surgical Centers and Others.

Geographically, global oncology market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions 

North America region is the largest contributor to the oncology market in the forecast period 2020-2028 and Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.

Key players in global oncology market are Roche, BMS Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceuticals, Pfizer Inc., Eli Lilly, Merck & Co., Amgen, Abbvie, Allogene Therapeutics, Juno Therapeutics, Morphosys, Arcus Biosciences, Atreca, Autolus, Novocure among others

The companies have come up with various promotional activities in from of launch, investment, acquisition and other, for instance:

  • Boston Scientific announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc. a company headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceuticals 
  • Medtronic Plc announced its U.S. launch of OptiSphere (TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular tumors

Hence, tremendous progress have been made over the last decade and yet a lot more to come in the recent years.

Available Customizations

In addition to the market data for oncology market, Delvens. offers client-centric report and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, conference like Jefferies conference)—to identify and collect information useful for this study of the oncology market. The purpose of secondary research was to identify and collection of extensive, technical, market-oriented, and commercial study the global oncology market. Through secondary the market is classified and segmented as per of industry trend, development, regional market. Product and technology development. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the oncology market.

The primary respondent breakdown is provided below:

Needle Market – Trends Forecast Till 2028

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validating the total revenue of the oncology market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data we contact primary respondent in order to gain 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for oncology market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Features

Description

Market Revenue In 2020

USD 175.4 billion

Growth Rate

CAGR of 7.1% during the forecasting period, 2020-2028

Historical Data

2017-2018

Forecast Years

2020-2028

Base Year 

2019

Units Considered

Revenue in USD billion and CAGR from 2020 to 2028

Report Segmentation

Areas, Cancer Type, Treatment, Technology, Drugs, Stage, End-User and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Roche, BMS Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceuticals, Pfizer Inc., Eli Lilly, Merck & Co., Amgen, Abbvie, Allogene Therapeutics, Juno Therapeutics, Morphosys, Arcus Biosciences, Atreca, Autolus, Novocure among others

Available Customization 

In addition to the market data for the oncology market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.